Deepak Nath, PhD, is Chief Executive Officer of Smith+Nephew, the portfolio medical technology business. Smith+Nephew’s global business units span Orthopaedics, Sports Medicine & ENT and Advanced Wound Management and generated annual sales of $5.8 billion in 2024.
Deepak joined Smith+Nephew from Siemens Healthineers (2018-2022) where most recently he was President of the Diagnostics business segment responsible for $6 billion of sales and 15,000 employees. Prior to Siemens Healthineers, Deepak held a number of senior roles at Abbott Laboratories Inc (2007-2017) rising to become President of Abbott Vascular and an Executive Officer of Abbott Laboratories. He also worked for Amgen (2004-2007) and McKinsey and Company (2000-2004).
Deepak holds BSc and MSc degrees in Mechanical Engineering and a PhD in Theoretical Mechanics from the University of California, Berkeley, and started his career as a scientist at Lawrence Livermore National Laboratory (1998-2000).